Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions

The benefit lasts even if you stop taking the drug, study finds

HealthDay SHARE

In related findings published in the same issue of the journal, an international team of researchers reported that regular aspirin use at doses ranging from 81 milligrams to 325 mg appeared to collectively lower the absolute risk for developing any kind of precancerous colorectal lesion by almost 7 percent. And in relative terms -- when compared with taking no NSAIDs at all -- those patients taking aspirin achieved a 28 percent reduction in their risk for developing advanced lesions.

More information

For more on colorectal cancer, visit the U.S. National Cancer Institute.

Copyright © 2011 HealthDay. All rights reserved.